GlycoMimetics Statistics
Total Valuation
GlycoMimetics has a market cap or net worth of $19.03 million. The enterprise value is $8.37 million.
Important Dates
The last earnings date was Thursday, February 13, 2025, after market close.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlycoMimetics has 64.51 million shares outstanding. The number of shares has increased by 1.79% in one year.
| Current Share Class | 64.51M |
| Shares Outstanding | 64.51M |
| Shares Change (YoY) | +1.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.60% |
| Owned by Institutions (%) | 24.05% |
| Float | 42.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.58 |
| P/TBV Ratio | 3.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.92 |
| Quick Ratio | 1.88 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -173.25% and return on invested capital (ROIC) is -91.11%.
| Return on Equity (ROE) | -173.25% |
| Return on Assets (ROA) | -72.04% |
| Return on Invested Capital (ROIC) | -91.11% |
| Return on Capital Employed (ROCE) | -611.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.08M |
| Employee Count | 35 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.14% in the last 52 weeks. The beta is 1.82, so GlycoMimetics's price volatility has been higher than the market average.
| Beta (5Y) | 1.82 |
| 52-Week Price Change | -91.14% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 53.33 |
| Average Volume (20 Days) | 3,626,928 |
Short Selling Information
The latest short interest is 2.03 million, so 3.15% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 2.24M |
| Short % of Shares Out | 3.15% |
| Short % of Float | 4.75% |
| Short Ratio (days to cover) | 5.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -32.51M |
| Pretax Income | -39.11M |
| Net Income | -37.88M |
| EBITDA | -32.47M |
| EBIT | -32.51M |
| Earnings Per Share (EPS) | -$0.59 |
Full Income StatementBalance Sheet
The company has $10.72 million in cash and $66,844 in debt, giving a net cash position of $10.65 million or $0.17 per share.
| Cash & Cash Equivalents | 10.72M |
| Total Debt | 66,844 |
| Net Cash | 10.65M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 5.31M |
| Book Value Per Share | 0.08 |
| Working Capital | 5.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.10 million and capital expenditures -$9,972, giving a free cash flow of -$31.11 million.
| Operating Cash Flow | -31.10M |
| Capital Expenditures | -9,972 |
| Free Cash Flow | -31.11M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |